Beijing Tong RenTang | Sustainability Performance
Produces and distributes traditional Chinese medicine products and healthcare offerings.
1669
China
10,001+ employees
Pharmaceuticals
$10B+ in revenue
$100M - 500M in profitability
Submit or report inaccurate dataDownload Company InsightsⓘBy downloading this report, you'll receive the most insightful and detailed analysis of the company's sustainability performance, compared to its peers. It includes key industry trends, carbon and energy intensity, nature impact, social metrics, and an in-depth look at key risks and controversies.
Sustainability Ranking & Industry Benchmark
#11261
Overallⓘ#809
in Chinaⓘ#267
in PharmaceuticalsⓘSustainability Maturity
ⓘSustainability Intent
ⓘOverview
Environmental
Energy consumptionWater ManagementAir & land impactNature and biodiversitySocial
Diversity and InclusionPay GapsExternalitiesGovernance
SDG Impact
Leading
Critical
Controversy level
- Beijing Tong Ren Tang Co (Shanghai-listed 600085.SH, one of China's largest state-affiliated traditional Chinese medicine (TCM) makers, ~350-year heritage brand) faced the contested December 2018 sustained Beijing Tongrentang Jiangsu expired Ejiao (donkey-hide gelatin) subsidiary scandal (Chinese CCTV expose alleged Tongrentang Bee Industry used expired honey raw material, driving National Medical Products Administration (NMPA) enforcement, revocation of the subsidiary's 'China Time-honored Brand' status and RMB 14+ million penalties), plus sustained scrutiny over Chinese TCM endangered-species-derived ingredient sourcing (musk, bezoar) NGO criticism affecting Tong Ren Tang institutional shareholders.
